-
1.发明申请
公开(公告)号：WO2010106555A3
公开(公告)日：2010-09-23
申请号：PCT/IN2010/000157
申请日：2010-03-17
Applicant: DHANRAJ, Amin, Purnima , SHANTILAL, Doshi, Bimalkumar , CHANDRAKUMAR, Shah, Gautam , PRAVIN, Shah, Sejal , PANNALAL, Jain, Satishkumar , SINGH, Pirthi, Pal, Singh, Partap , PARSHURAM, Sawant, Kiran
Inventor： DHANRAJ, Amin, Purnima , PRAVIN, Shah, Sejal , PANNALAL, Jain, Satishkumar , SINGH, Pirthi, Pal, Singh, Partap , PARSHURAM, Sawant, Kiran
Abstract: The present invention relates to the process for preparing the pre-granulated directly compressible cellulose ether polymer granular assemblies. The present invention further provides the pre-granulated directly compressible cellulose ether polymer granular assemblies, composition comprising pre-granulated directly compressible cellulosic ether polymer granular assemblies and an active constituent and dosage forms prepared by the direct compression of the composition comprising a pre-granulated directly compressible cellulosic ether polymer granular assemblies and an active constituent.
-
Patent Agency Ranking
公开(公告)号：WO2012098562A3
公开(公告)日：2012-11-29
申请号：PCT/IN2012000041
申请日：2012-01-17
Applicant: PANACEA BIOTEC LTD , JAIN RAJESH , SINGH SARABJIT , SINGH PARAMJIT , SINGH PIRTHI PAL
Inventor： JAIN RAJESH , SINGH SARABJIT , SINGH PARAMJIT , SINGH PIRTHI PAL
CPC classification number: A61K9/0053 , A61K9/0095 , A61K33/24 , A61K47/02 , A61K47/14 , A61K47/26 , A61K47/38
Abstract: The present invention relates to liquid oral pharmaceutical compositions of lanthanum and its pharmaceutically acceptable salts thereof. The present invention further relates to preparation of liquid oral pharmaceutical compositions of lanthanum and its salts and also provides use of such compositions in treating hyperphosphatemia in patients.
Abstract translation: 本发明涉及镧及其药学上可接受的盐的液体口服药物组合物。 本发明进一步涉及制备镧及其盐的液体口服药物组合物，并且还提供了这种组合物在治疗患者中的高磷酸盐血症中的用途。
-
3.发明申请
公开(公告)号：WO2010106557A3
公开(公告)日：2011-03-10
申请号：PCT/IN2010000163
申请日：2010-03-19
Applicant: PANACEA BIOTEC LTD , JAIN RAJESH , SINGH SARABJIT , SINGH PARAMJIT , SINGH PIRTHI PAL
Inventor： JAIN RAJESH , SINGH SARABJIT , SINGH PARAMJIT , SINGH PIRTHI PAL
CPC classification number: A61K33/24 , A61K9/0056 , A61K9/2054
Abstract: The present invention discloses the premix pharmaceutical formulation comprising anhydrous lanthanum carbonate. The present invention further relates to a stable pharmaceutical formulation comprising a therapeutically effective amount of anhydrous lanthanum carbonate and pharmaceutically acceptable carrier and/or excipients, with the proviso that the said formulation is substantially free of monosaccharides or disaccharides. Further the said formulation is substantially free of amino acids and/or stabilizers. The process of preparing such formulations is also described.
Abstract translation: 本发明公开了包含无水碳酸镧的预混药物制剂。 本发明还涉及包含治疗有效量的无水碳酸镧和药学上可接受的载体和/或赋形剂的稳定药物制剂，条件是所述制剂基本上不含单糖或二糖。 此外，所述制剂基本上不含氨基酸和/或稳定剂。 还描述了制备这种制剂的方法。
-
公开(公告)号：WO2012098562A2
公开(公告)日：2012-07-26
申请号：PCT/IN2012/000041
申请日：2012-01-17
Applicant: PANACEA BIOTEC LIMITED , JAIN, Rajesh , SINGH, Sarabjit , SINGH, Paramjit , SINGH, Pirthi Pal
Inventor： JAIN, Rajesh , SINGH, Sarabjit , SINGH, Paramjit , SINGH, Pirthi Pal
CPC classification number: A61K9/0053 , A61K9/0095 , A61K33/24 , A61K47/02 , A61K47/14 , A61K47/26 , A61K47/38
Abstract: The present invention relates to liquid oral pharmaceutical compositions of lanthanum and its pharmaceutically acceptable salts thereof. The present invention further relates to preparation of liquid oral pharmaceutical compositions of lanthanum and its salts and also provides use of such compositions in treating hyperphosphatemia in patients.
Abstract translation: 本发明涉及镧的液体口服药物组合物及其药学上可接受的盐。 本发明还涉及镧及其盐的液体口服药物组合物的制备，并且还提供了这些组合物在患者中治疗高磷血症的用途。
-
5.发明申请
公开(公告)号：WO2010106557A2
公开(公告)日：2010-09-23
申请号：PCT/IN2010/000163
申请日：2010-03-19
Applicant: PANACEA BIOTEC LIMITED , JAIN, Rajesh , SINGH, Sarabjit , SINGH, Paramjit , SINGH, Pirthi, Pal
Inventor： JAIN, Rajesh , SINGH, Sarabjit , SINGH, Paramjit , SINGH, Pirthi, Pal
IPC: A61K33/24
CPC classification number: A61K33/24 , A61K9/0056 , A61K9/2054
Abstract: The present invention discloses the premix pharmaceutical formulation comprising anhydrous lanthanum carbonate. The present invention further relates to a stable pharmaceutical formulation comprising a therapeutically effective amount of anhydrous lanthanum carbonate and pharmaceutically acceptable carrier and/or excipients, with the proviso that the said formulation is substantially free of monosaccharides or disaccharides. Further the said formulation is substantially free of amino acids and/or stabilizers. The process of preparing such formulations is also described.
Abstract translation: 本发明公开了包含无水碳酸镧的预混药物制剂。 本发明还涉及包含治疗有效量的无水碳酸镧和药学上可接受的载体和/或赋形剂的稳定药物制剂，条件是所述制剂基本上不含单糖或二糖。 此外，所述制剂基本上不含氨基酸和/或稳定剂。 还描述了制备这种制剂的方法。
-
6.发明申请DIRECTLY COMPRESSIBLE PRE-GRANULATED CELLULOSE ETHER POLYMER AND PROCESS FOR PREPARING THE SAME 审中-公开直径可压缩的预成粒纤维素醚聚合物及其制备方法
公开(公告)号：WO2010106555A2
公开(公告)日：2010-09-23
申请号：PCT/IN2010000157
申请日：2010-03-17
Applicant: DHANRAJ AMIN PURNIMA , SHANTILAL DOSHI BIMALKUMAR , CHANDRAKUMAR SHAH GAUTAM , PRAVIN SHAH SEJAL , PANNALAL JAIN SATISHKUMAR , SINGH PIRTHI PAL SINGH PARTAP , PARSHURAM SAWANT KIRAN
Inventor： DHANRAJ AMIN PURNIMA , PRAVIN SHAH SEJAL , PANNALAL JAIN SATISHKUMAR , SINGH PIRTHI PAL SINGH PARTAP , PARSHURAM SAWANT KIRAN
IPC: A61K9/20
CPC classification number: A61K47/38 , A61K9/2013 , A61K9/2018 , A61K9/2054 , A61K9/2095
Abstract: The present invention relates to the process for preparing the pre-granulated directly compressible cellulose ether polymer granular assemblies. The present invention further provides the pre-granulated directly compressible cellulose ether polymer granular assemblies, composition comprising pre-granulated directly compressible cellulosic ether polymer granular assemblies and an active constituent and dosage forms prepared by the direct compression of the composition comprising a pre-granulated directly compressible cellulosic ether polymer granular assemblies and an active constituent.
Abstract translation: 本发明涉及制备预颗粒化直接可压缩纤维素醚聚合物颗粒组件的方法。 本发明还提供了预颗粒化的直接可压缩的纤维素醚聚合物颗粒组合物，其包含预颗粒化的可直接可压缩的纤维素醚聚合物颗粒组件，以及通过直接压制组合物制备的活性成分和剂型，所述组合物包含直接预颗粒化 可压缩纤维素醚聚合物颗粒组件和活性成分。
-
-
-
-
-
Search Results
6
records
(took 0.007 seconds)
